Marti Technologies, Inc. announced that it has appointed Oguz Erkan as its new Chief Financial Officer, effective May 17, 2024. Oguz Erkan replaces the Company?s former CFO, Cem Yasar Ozey. Oguz Erkan has an extensive 22-year career holding prominent roles in finance, strategy, and project management across various industries.

Preceding his appointment at Marti, he served as the Country CFO of GlaxoSmithKline Türkiye, since July 2019. Prior to that time, Mr. Erkan held the position of Country CFO at GSK Consumer Healthcare Türkiye (now Haleon) from March 2017 to July 2019, and served as the Regional Supply Chain Finance Director at GSK MEA & CIS & Russia from April 2015 to March 2017. Between June 2006 and April 2015, he held various other positions at GSK with increasing responsibilities such as Pricing, SAP Implementation and CEO of the Strategy Group in global headquarters.

From August 2002 until June 2006, he had various finance roles in Arçelik-Beko. Known for his adept leadership in managing diverse teams across international boundaries and navigating complex organizational structures, Mr. Erkan possesses a comprehensive understanding of finance across multiple sectors. He earned his Bachelor of Arts degree in Business Administration from Koç University and an Executive MBA also from Koç University.